Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma de Jong

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 5, 2024
Low-Risk Staphylococcus aureus Bacteremia Patients Do Not Require Routine Diagnostic Imaging: A Multicenter, Retrospective, Cohort StudyMarianne M C Hendriks, Kris S A Schweren, Ayden Kleij, et al.
Science Advances|May 14, 2025
Interleukin-4 modulates type I interferon to augment antitumor immunityHannah V Newnes, Jesse D Armitage, Anthony C Buzzai, et al.
Scientific Reports|February 24, 2026
Mesothelioma location influences the tumour microenvironment and immune checkpoint therapy response in preclinical modelsM Lizeth Orozco Morales, Sally M Lansley, Wee Loong Chin, et al.
Science Translational Medicine|July 19, 2019
Sensitization to immune checkpoint blockade through activation of a STAT1/NK axis in the tumor microenvironmentRachael M Zemek, Emma De Jong, Wee Loong Chin, et al.
Oncoimmunology|April 30, 2024
Immune checkpoint therapy responders display early clonal expansion of tumor infiltrating lymphocytesJoel Kidman, Rachael M Zemek, John-William Sidhom, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 21, 2020
Ivacaftor or lumacaftor/ivacaftor treatment does not alter the core CF airway epithelial gene response to rhinovirusEmma De Jong, Luke W Garratt, Kevin Looi, et al.
Iscience|January 5, 2022
PPARα and PPARγ activation is associated with pleural mesothelioma invasion but therapeutic inhibition is ineffectiveM Lizeth Orozco Morales, Catherine A Rinaldi, Emma de Jong, et al.
The European Respiratory Journal|October 22, 2021
Biomarker signatures for progressive idiopathic pulmonary fibrosisBritt Clynick, Tamera J Corte, Helen E Jo, et al.
The Journal of Allergy and Clinical Immunology|June 1, 2022
Airway and parenchymal transcriptomics in a novel model of asthma and COPD overlapXiaofan Tu, Richard Y Kim, Alexandra C Brown, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2026
The Vertebrate Genomes Project Phase I: A global reference genome resourceGiulio Formenti, Dominic E Absolon, Linelle Ann L Abueg, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 5, 2024
Low-Risk Staphylococcus aureus Bacteremia Patients Do Not Require Routine Diagnostic Imaging: A Multicenter, Retrospective, Cohort StudyMarianne M C Hendriks, Kris S A Schweren, Ayden Kleij, et al.
Science Advances|May 14, 2025
Interleukin-4 modulates type I interferon to augment antitumor immunityHannah V Newnes, Jesse D Armitage, Anthony C Buzzai, et al.
Scientific Reports|February 24, 2026
Mesothelioma location influences the tumour microenvironment and immune checkpoint therapy response in preclinical modelsM Lizeth Orozco Morales, Sally M Lansley, Wee Loong Chin, et al.
Science Translational Medicine|July 19, 2019
Sensitization to immune checkpoint blockade through activation of a STAT1/NK axis in the tumor microenvironmentRachael M Zemek, Emma De Jong, Wee Loong Chin, et al.
Oncoimmunology|April 30, 2024
Immune checkpoint therapy responders display early clonal expansion of tumor infiltrating lymphocytesJoel Kidman, Rachael M Zemek, John-William Sidhom, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 21, 2020
Ivacaftor or lumacaftor/ivacaftor treatment does not alter the core CF airway epithelial gene response to rhinovirusEmma De Jong, Luke W Garratt, Kevin Looi, et al.
Iscience|January 5, 2022
PPARα and PPARγ activation is associated with pleural mesothelioma invasion but therapeutic inhibition is ineffectiveM Lizeth Orozco Morales, Catherine A Rinaldi, Emma de Jong, et al.
The European Respiratory Journal|October 22, 2021
Biomarker signatures for progressive idiopathic pulmonary fibrosisBritt Clynick, Tamera J Corte, Helen E Jo, et al.
The Journal of Allergy and Clinical Immunology|June 1, 2022
Airway and parenchymal transcriptomics in a novel model of asthma and COPD overlapXiaofan Tu, Richard Y Kim, Alexandra C Brown, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2026
The Vertebrate Genomes Project Phase I: A global reference genome resourceGiulio Formenti, Dominic E Absolon, Linelle Ann L Abueg, et al.
Pageof 4